EPA guidance on the early intervention in clinical high risk states of psychoses. - Wikidata - awgldk - TriplyDB

EPA guidance on the early intervention in clinical high risk states of psychoses.

EPA guidance on the early intervention in clinical high risk states of psychoses.

http://www.wikidata.org/entity/Q34668473

about

Early interventions for prodromal stage of psychosis Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.A critique of the "ultra-high risk" and "transition" paradigm.The Youth Mental Health Risk and Resilience Study (YouR-Study).No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome Predicting the onset of psychosis in patients at clinical high risk: practical guide to probabilistic prognostic reasoning.Altering the course of schizophrenia: progress and perspectives.Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.Prediction and prevention of psychosis: current progress and future tasks.Guidelines for the Pharmacotherapy of Schizophrenia in Adults.Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Adults.Polish individuals with an at-risk mental state: demographic and clinical characteristics.Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Children and Youth.Canadian Practice Guidelines for Comprehensive Community Treatment for Schizophrenia and Schizophrenia Spectrum Disorders.Predictors of treatment response to psychological interventions in people at clinical high risk of first-episode psychosis.Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project.Diagnostic Categories: Provisional, Not Otherwise Classified, or Place-holder?Coping with Unusual ExperienceS for 12-18 year olds (CUES+): a transdiagnostic randomised controlled trial of the effectiveness of cognitive therapy in reducing distress associated with unusual experiences in adolescent mental health services: study Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis.Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders.Physical Health and Drug Safety in Individuals with Schizophrenia.Increased Striatal and Reduced Prefrontal Cerebral Blood Flow in Clinical High Risk for Psychosis.Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.Clinical high risk for psychosis in children and adolescents: a systematic review.Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.Age effect on prevalence of ultra-high risk for psychosis symptoms: replication in a clinical sample of an early detection of psychosis service.Early referral and comorbidity as possible causes of the declining transition rate in subjects at clinical high risk for psychosis.Restricted attention to social cues in schizophrenia patients.Psychosis-risk criteria in the general population: frequent misinterpretations and current evidence.Canadian Schizophrenia Guidelines: Introduction and Guideline Development Process.Development and interrater reliability of the UK Mental Health Triage Scale.[Should antipsychotics be used in prodromal stages of schizophrenia to prevent psychosis? Con].Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.Identifying and treating the prodromal phases of bipolar disorder and schizophrenia

P2860

Q26471731-28460808-6BC1-42C6-A577-21556A09AFA9 Q26771515-DBF4B2EA-8320-40BC-947F-546003AE6E58 Q30362549-C544FFA1-A670-4EE1-B3DB-8498C3A6247B Q33670654-94308D47-2C87-49B2-86F4-576E53620732 Q36261704-E2D20EAB-38D2-402C-918D-D73B04EE97BC Q36345854-9D25E1D0-DD68-4CCF-8B01-359D30103420 Q36910682-44C75521-B89E-4D1B-88BE-17BCEA5B180E Q37274686-1A69B0DD-7345-4933-9EFE-C5D3FC6452A5 Q38705227-D76903E1-15B1-467F-9454-A9F1400A5179 Q38759421-0E722F0C-4766-4051-ABC8-612F92B2D21C Q38902686-E481746F-7ABF-46BE-A9C0-A0F9416C06B7 Q39123249-B47F1E14-8751-4904-9353-5CC9782EA3FD Q39432209-E401D31E-3939-4C6F-9E7B-B0BBF7D87B49 Q39432218-A9E7BAB7-9C50-4DE2-9B9F-551F1DE1E408 Q39824871-846A5C3B-9032-4D75-8715-591FC02708B1 Q39905473-DE939C41-494F-4463-ADA0-9512542E3120 Q40050496-0F1450A0-70FE-4040-8601-FC3F89EA550A Q40050502-71C998E1-F40C-4A24-B58F-F8177195B697 Q40135642-1AED02E0-7ECA-4E0E-9DB7-774712068936 Q41068640-A7E24897-FBE1-4B58-B49D-074D0A106D9D Q42650193-8EB77E74-7482-4756-9E91-FC24EB36616E Q47094819-90DA8DD2-E570-49D6-A0BB-E2E84922784E Q47307661-32715EC5-2299-4A34-8F2A-5737C4249F56 Q47316102-7B37CF7C-41A2-4C81-8C8F-E598BFABB7E0 Q47316111-4B04CD5B-D3E8-4B0A-B19A-13DE2A04A828 Q47319403-C01CCB95-CD39-41B3-BE29-B1A2725EEB93 Q47357393-08AB3055-D29F-4DA7-832C-49FEC2512C0D Q47578112-08801B66-E513-42C4-AC4C-F832EA8CFF6E Q47621148-7B52A5F0-3A4D-4663-B10A-1854E17F3AEA Q47622971-BC1C2127-92DC-4293-A838-CC9F44F08790 Q47891364-86C99704-8E09-4517-9B8C-09942BF01C0B Q48527862-E121332D-DF6F-43CD-976D-78615AC7EC1D Q48610622-E387FA8E-7321-4857-B592-D760BCEF0664 Q49247390-BF00EA0A-E721-4961-A6FA-11925FD1FC7D Q50319545-D2AC5301-AF82-4D3D-9CA3-65A2B8A59D58 Q50535454-F2CF721D-7569-403C-956B-5F807BE88FA0 Q52860745-D36F944E-1FF0-4019-B652-218D12792A73 Q55361260-8F9CD777-4E45-496C-B3DB-19EA797CC245 Q55397391-831BCFE1-084B-4021-93E5-183FD1979C77 Q58575795-CB01A1B7-5E2E-473C-A367-35164561BCC2

P2860

EPA guidance on the early intervention in clinical high risk states of psychoses.

http://www.wikidata.org/entity/Q34668473

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

EPA guidance on the early intervention in clinical high risk states of psychoses.

@ast

EPA guidance on the early intervention in clinical high risk states of psychoses.

@en

EPA guidance on the early intervention in clinical high risk states of psychoses.

@nl

type

label

EPA guidance on the early intervention in clinical high risk states of psychoses.

@ast

EPA guidance on the early intervention in clinical high risk states of psychoses.

@en

EPA guidance on the early intervention in clinical high risk states of psychoses.

@nl

prefLabel

EPA guidance on the early intervention in clinical high risk states of psychoses.

@ast

EPA guidance on the early intervention in clinical high risk states of psychoses.

@en

EPA guidance on the early intervention in clinical high risk states of psychoses.

@nl

P1433

Q34668473-7F148DE9-1BFF-4BEE-9A47-155C19FC7D19

P1476

Q34668473-F81851DF-D0D6-424D-B996-A41CF84AC71A

P2093

Q34668473-07AF9162-68E0-4E85-9F66-B003A63A3EF9

Q34668473-2D37059B-93BF-4725-AA5D-38738B7FA4EE

Q34668473-3B5966B7-E2CF-462E-BF1B-5BD2C074531E

Q34668473-42D95EAD-C2A9-45DA-9C24-4F1141E5DF64

Q34668473-4BD99EF3-4AC8-4ABB-BED5-44BCFB16256B

Q34668473-678AF564-6520-46CA-ABA0-468E870C1881

Q34668473-7F58E6E5-C656-4AD5-9C4B-80A7902AD70B

Q34668473-B3E55C38-4940-44F6-ABD6-ADAD83C5FFAA

Q34668473-DF847631-7E94-4FA5-8307-F9E9AA4DD59E

Q34668473-F1F0D844-23AA-4846-B913-BB37A1160607

P304

Q34668473-6C1C2A8D-85BD-40B3-BA0C-8D4121FC5D36

P31

Q34668473-CCBC9117-2DA6-43D8-99E4-4D3397D8791A

P356

Q34668473-08FC4CB9-16F7-49BA-A4F4-5B65DF4E5CE0

P407

Q34668473-A00D0167-2F05-4210-BB5D-37844A92F6C7

P433

Q34668473-3152AEF3-C62A-46AD-AC1C-69062A62B8CC

P478

Q34668473-C77D9AAE-4ED3-49F5-954C-A284768530F5

P50

Q34668473-0837B8BA-6983-4B39-BE63-01CE273BC151

Q34668473-1F813B2F-DB59-4795-82C8-3320A94ACF66

Q34668473-54C2C26B-7620-4195-9EBD-326DCDE79961

Q34668473-FE7B43E7-C7DD-45C7-80EE-8222A94254E9

P577

Q34668473-2B7BB152-B477-4E36-A72D-90C65CEF96F8

P5875

Q34668473-805E8CA7-6401-4131-8CFC-F7BC35F66E51

P698

Q34668473-B206C5DC-F01E-4816-8BBA-584A92B0F251

P356

J.EURPSY.2015.01.013

P1433

European Psychiatry

P1476

EPA guidance on the early intervention in clinical high risk states of psychoses

@en

P2093

A Meneghelli

http://www.w3.org/2001/XMLSchema#string

A Morrison

http://www.w3.org/2001/XMLSchema#string

B G Schimmelmann

http://www.w3.org/2001/XMLSchema#string

F Schultze-Lutter

http://www.w3.org/2001/XMLSchema#string

J Klosterkötter

http://www.w3.org/2001/XMLSchema#string

M Marshall

http://www.w3.org/2001/XMLSchema#string

N P Maric

http://www.w3.org/2001/XMLSchema#string

R K R Salokangas

http://www.w3.org/2001/XMLSchema#string

S J Schmidt

http://www.w3.org/2001/XMLSchema#string

S Ruhrmann

http://www.w3.org/2001/XMLSchema#string

P304

388-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURPSY.2015.01.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Merete Nordentoft

Mark van der Gaag

Anita Riecher-Rössler

P577

2015-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273125949

http://www.w3.org/2001/XMLSchema#string

P698

25749390

http://www.w3.org/2001/XMLSchema#string